Low-dose versus high-dose oxytocin augmentation of labor--a randomized trial

American Journal of Obstetrics and Gynecology
E M XenakisM D Berkus

Abstract

Our purpose was to compare the efficacy and safety of low-dose versus high-dose oxytocin regimens in the augmentation of labor. Three hundred ten term pregnancies requiring augmentation of labor underwent randomization to receive either a low-dose or high-dose oxytocin augmentation regimen. Maternal demographics, labor-delivery data, and neonatal outcome were compared. The high-dose oxytocin group had a significantly lower cesarean section rate, regardless of parity (10.4% vs 25.7%, p < 0.001), with no differences in maternal complications and neonatal outcomes. The time needed to correct the labor abnormality was also significantly decreased (1.24 +/- 1.4 hours vs 3.12 +/- 1.6 hours, p < 0.001) in the high-dose group. The use of high-dose oxytocin regimen benefits both nulliparous and multiparous women requiring labor augmentation by significantly lowering both the time necessary to correct the labor abnormality and the need for cesarean section.

References

Sep 1, 1989·American Journal of Obstetrics and Gynecology·J A ThorpD A Johnston
Mar 1, 1987·Clinical Obstetrics and Gynecology·J Seitchik
Dec 15, 1985·American Journal of Obstetrics and Gynecology·K J LevenoJ A Pritchard

❮ Previous
Next ❯

Citations

Nov 27, 1999·Obstetrics and Gynecology·L J VoutsosD M Cantor
Jul 15, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·T Schmitz, E Meunier
Nov 5, 1997·Clinical Obstetrics and Gynecology·D J Dudley
Aug 4, 2006·Clinical Obstetrics and Gynecology·Jennifer G Smith, David C Merrill
Apr 5, 2000·MCN. the American Journal of Maternal Child Nursing·S Clayworth
Dec 5, 2009·Obstetrics and Gynecology International·Naomi Schneid-KofmanAriela Burg
May 4, 2011·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·M I BankL Krebs
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·N ArnottP Lynch
May 11, 2010·American Journal of Obstetrics and Gynecology·Shu-Qin WeiWilliam D Fraser
Mar 22, 2008·American Journal of Obstetrics and Gynecology·Edward J Hayes, Louis Weinstein
Sep 28, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Lily LeeHussam Azzam
Sep 28, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Lily LeeHussam Azzam
Dec 2, 2004·The Annals of Pharmacotherapy·John H PatkaAngela K Johnston
Oct 7, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A Jamal, R Kalantari
Mar 10, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Yoram AbramovVivian Barak
Oct 11, 2014·The Cochrane Database of Systematic Reviews·Aaron BuddenAmanda Henry
Feb 2, 2008·Obstetrics and Gynecology·David A Grimes, Kenneth F Schulz
Aug 25, 2009·Obstetrics and Gynecology·Shu-Qin WeiWilliam D Fraser
Jul 16, 2013·The Cochrane Database of Systematic Reviews·Sara KenyonRintaro Mori
Jul 11, 2020·Obstetrics and Gynecology·Michael J BeninatiErika F Werner
Sep 21, 2020·Journal of Perinatal Medicine·Rehab Abdelhamid AboshamaMohamed Sobhy Bakry
Aug 1, 1997·Obstetrical & Gynecological Survey·J C Glantz, T J McNanley
Apr 23, 2020·BMC Pregnancy and Childbirth·Melese Gezahegn TesemmaDesta Hiko Gemeda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.